Cancer Research and Treatment10.4143/crt.2014.46.1.19201446119-26A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by ChemotherapyHee Yeon Lee, Hoon-Kyo Kim, Kyung Hee Lee, Bong-Seog Kim, Hong Suk Song, Sung Hyun Yang, Joon Hee Kim, Yeul Hong Kim, Jong Gwang Kim, Sang-We Kim, Dong-Wan Kim, Si-Young Kim, Hee Sook Park,
The Lancet Oncology10.1016/s1470-2045(15)00520-32016173332-344Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority studyGábor Kovács, Antonio E Wachtel, Elena V Basharova, Tulla Spinelli, Pierre Nicolas, Edita Kabickova,
Annals of Oncology10.1093/annonc/mdy444.009201829ix131A randomized, double blind, placebo-controlled study evaluating efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamideW. Nipondhkit,,
Clinical Oncology10.1016/s0936-6555(05)80086-x199356358-363A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapyT.J. Priestman, J.T. Roberts, B.K. Upadhyaya,
Gastroenterology10.1016/s0016-5085(11)62371-820111405S-572A Randomized Double-Dummy, Double Blind, Misoprostol Comparative Clinical Trial to Evaluate and Safety of Rebamipide in the Prevention of NSAID-Induced Gastrointestinal ComplicationJin Hwan Jung, Soo-Heon Park,
Pediatric Blood & Cancer10.1002/pbc.290022021686Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy‐induced nausea and vomiting among children: A comparative randomized double‐blind controlled trialJittra Ruktrirong, Chanchai Traivaree, Chalinee Monsereenusorn, Apichat Photia, Nawachai Lertvivatpong, Piya Rujkijyanont,,
Annals of Oncology10.1093/annonc/mdt5342014251300Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial,,
Oncology10.1159/0002277231997545380-386Ondansetron Suppository: A Randomised, Double-Blind, Double-Dummy, Parallel-Group Comparison with Oral Ondansetron for the Prevention of Cyclophosphamide Induced Emesis and NauseaN.G.P. Davidson, W. Paska, S. Van Belle, L. Goedhals, B. McQuade, J. McRae,
The Lancet Oncology10.1016/s1470-2045(08)70313-92009102115-124Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trialMitsue Saito, Kenjiro Aogi, Ikuo Sekine, Hirohisa Yoshizawa, Yasuhiro Yanagita, Hiroshi Sakai, Kenichi Inoue, Chiyoe Kitagawa, Takashi Ogura, Shoichi Mitsuhashi,
Journal of the American Academy of Dermatology10.1016/j.jaad.2009.11.2072010623AB41Double-blind, double-dummy, randomized, placebo-controlled, five-armed, multicenter phase II/III study to evaluate the efficacy and safety of different concentrations of isotretinoin versus doxycycline in the treatment of rosacea, subtype II and III,